Cost-Effectiveness of Apixaban Compared to Low Molecular Weight Heparin/ Edoxaban for Treatment and Prevention of Recurrent Venous Thromboembolism
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.781
https://www.valueinhealthjournal.com/article/S1098-3015(15)02857-0/fulltext
Title :
Cost-Effectiveness of Apixaban Compared to Low Molecular Weight Heparin/ Edoxaban for Treatment and Prevention of Recurrent Venous Thromboembolism
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02857-0&doi=10.1016/j.jval.2015.09.781
First page :
A375
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
223